2nd International Conference on Translational Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, USA

Upcoming Conference

Home seperator ABOUT seperator OPEN ACCESS seperator CONFERENCES seperator JOURNALS seperator FAQs seperator CONTACT
Translational Medicine 2013
Home
Gallery
Translational Medicine 2013 Report

The 2nd International Conference on Translational Medicine (Translational Medicine-2013) took place at the Holiday Inn Chicago-North shore, USA during August 5-7, 2013. It was organized by OMICS Group and saw a good response from the scientific community. The three day program witnessed thought provoking speeches from experts which focused on the theme "Exploring New Horizons of Translational Medicine".

Sigma-Aldrich Co. LLC. proudly sponsored the event and showcased their new innovations.

The highlights of the meeting were the eponymic Keynote lectures from

  • Maurizio Chiriva Internati - Texas Tech University, USA
  • Michael Retsky - Harvard School of Public Health, USA
  • Antonio Gomez Munoz - University of the Basque Country, Spain
  • Gerson Chadi - University of Sao Paulo, Brazil

Organizations from various countries took part in the conference. Some of them were

  • Biodesix, Inc., USA
  • GlaxoSmithKline, USA
  • Recombinant By Deloitte, USA
  • Celgene Cellular  Therapeutics, USA
  • Cedars-Sinai Medical Center, USA
  • ProFibrix, Inc., USA
  • Frohna Biotech Consulting, USA
  • The Wisconsin Parkinson Association, USA
  • Ako Kasei co., Ltd, Japan

Translational Medicine-2013 played an important role in promoting multidisciplinary interactions between science and medicine to enhance disease research and drug development. The program covered current and emerging challenges in the biopharmaceutical industry and strategies for drug development.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank all the Organizing Committee Members of Translational Medicine-2013 for their support throughout the planning of this conference. With valuable feedback from the conference, OMICS Group would like to announce the commencement of "3rd International Conference on Translational Medicine" September 24-26, 2014 Valencia, Spain.



Expert Presentations
Paul A. Frohna

ProFibrix, Inc.,

USA
Xiaojiang Cui

Cedars-Sinai Medical Center

USA
Uri Herzberg

Celgene Cellular Therapeutics

USA
Dan Housman

Recombinant by Deloitte

USA
Immanuel Freedman

GlaxoSmithKline

USA
Subramani Mani

University of New Mexico

USA
Sevtap Savas

Memorial University of Newfoundland

Canada
Nan Hu

University of Utah

USA
Michael Retsky

Harvard School of Public Health

USA
Maurizio Chiriva Internati

Texas Tech University

USA
Thomas Fritsch

The Wisconsin Parkinson Association

USA
Fayyad-Kazan Hussein

Universite Libre de Bruxelles

Belgium
Antonio Gomez Munoz

University of the Basque Country

Spain
Gerson Chadi

University of Sao Paulo

Brazil
B.J. Nickoloff

Michigan State University

USA
Douglas K. Price

National Cancer Institute

USA
Rihova Blanka

Academy of Sciences of the Czech Republic

Czech Republic
Chanderdeep Tandon

Jaypee University of Information Technology

India
Ena Ray Banerjee

University of Calcutta

India
Conference: Translational Medicine 2013, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact:
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Translational Medicine, Advances in Pharmacoepidemiology & Drug Safety and Journal of Pharmacogenomics & Pharmacoproteomics
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved